Fulminant liver failure 30 year-old patient
https://doi.org/10.22416/1382-4376-2016-5-45-55
About the Authors
Anna F. SheptulinaRussian Federation
Sh. A. Ondos
Russian Federation
M. V. Mayevskaya
Russian Federation
V. T. Ivashkin
Russian Federation
References
1. Lee W.M., Larson A.M., Stravitz R.T. AASLD position paper: The management of acute liver failure: Update 2011. www.aasld.org/practiceguidelines/Documents/ AcuteLiverFailureUpdate2011.pdf.
2. Lee H.W., Chang D.Y, Moon H.J., Chang H.Y., Shin E.C., Lee J.S., et al. Clinical factors and viral load influencing severity of acute hepatitis A. PLoS One 2015; 10(6): e0130728. doi: 10.1371/journal.pone.0130728. eCollection 2015.
3. Kim J.I., Kim Y.S., Jung Y.K., Kwon O.S., Kim Y.S., Ku Y.S., et al. Factors influencing the severity of acute viral hepatitis A. Korean J Hepatol 2010; 16(3): 295-300.
4. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31(5):929-38.
5. Glikson M., Galun E., Oren R., Tur-Kaspa R., Shouval D. Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine (Baltimore) 1992; 71(1): 14-23.
6. Ertekin V.1., Selimoğlu M.A., Orbak Z. An unusual combination of relapsing and cholestatic hepatitis A in childhood. Yonsei Med J 2003; 44(5):939-42.
7. Grünhage F., Spengler U., Fischer H.P., Sauerbruch T. Autoimmune hepatitis-sequel of a relapsing hepatitis A in a 75-year-old woman. Digestion 2004; 70(3):187-91.
8. Seo Y.S., Lee K.G., Jung E.S., An H., Kim J.H., Yeon J.E., et al. Clinical significance of the detection of antinuclear antibodies in patients with acute hepatitis A. Gut Liver 2011; 5(3):340-7.
9. Skoog S.M., Rivard R.E., Batts K.P., Smith C.I. Autoimmune hepatitis preceded by acute hepatitis A infection. Am J Gastroenterol 2002; 97(6):1568-9.
10. Blachier M., Leleu H., Peck-Radosavljevic M., Valla D.Ch., Roudot-Thoraval F. The burden of liver disease in Europe: A review of available epidemiological data. J Hepatol 2013; 58:593-608.
11. Yang F., Wang Q., Bian Z., Ren L.L., Jia J., Ma X. Autoimmune hepatitis: East meets west. J Gastroenterol Hepatol 2015; 30(8):1230-6.
12. Corrigan M., Hirschfield G.M., Oo Y.H., Adams D.H. Autoimmune hepatitis: an approach to disease understanding and management. Br Med Bull 2015; 114(1):181-91.
13. Licata A., Maida M., Cabibi D., Butera G., Macaluso F.S., Alessi N., et al. Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study. Dig Liver Dis 2014; 46(12):1116-20.
14. Hisamochi A., Kage M., Ide T., Arinaga-Hino T., Amano K., Kuwahara R., et al. An analysis of druginduced liver injury, which showed histological findings similar to autoimmune hepatitis. J Gastroenterol 2016; 51(6):597-607.
15. Singh G., Palaniappan S., Rotimi O., Hamlin P.J. Autoimmune hepatitis triggered by hepatitis A. Gut 2007; 56(2):304.
Review
For citations:
Sheptulina A.F., Ondos Sh.A., Mayevskaya M.V., Ivashkin V.T. Fulminant liver failure 30 year-old patient. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(5):45-55. (In Russ.) https://doi.org/10.22416/1382-4376-2016-5-45-55